In vitro cytotoxicity of surface modified bismuth nanoparticles
- PMID: 22802106
- DOI: 10.1007/s10856-012-4716-1
In vitro cytotoxicity of surface modified bismuth nanoparticles
Abstract
This paper describes in vitro cytotoxicity of bismuth nanoparticles revealed by three complementary assays (MTT, G6PD, and calcein AM/EthD-1). The results show that bismuth nanoparticles are more toxic than most previously reported bismuth compounds. Concentration dependent cytotoxicities have been observed for bismuth nanoparticles and surface modified bismuth nanoparticles. The bismuth nanoparticles are non-toxic at concentration of 0.5 nM. Nanoparticles at high concentration (50 nM) kill 45, 52, 41, 34 % HeLa cells for bare nanoparticles, amine terminated bismuth nanoparticles, silica coated bismuth nanoparticles, and polyethylene glycol (PEG) modified bismuth nanoparticles, respectively; which indicates cytotoxicity in terms of cell viability is in the descending order of amine terminated bismuth nanoparticles, bare bismuth nanoparticles, silica coated bismuth nanoparticles, and PEG modified bismuth nanoparticles. HeLa cells are more susceptible to toxicity from bismuth nanoparticles than MG-63 cells. The simultaneous use of three toxicity assays provides information on how nanoparticles interact with cells. Silica coated bismuth nanoparticles can damage cellular membrane yet keep mitochondria less influenced; while amine terminated bismuth nanoparticles can affect the metabolic functions of cells. The findings have important implications for caution of nanoparticle exposure and evaluating toxicity of bismuth nanoparticles.
Similar articles
-
Three-dimensional microtissue assay for high-throughput cytotoxicity of nanoparticles.Anal Chem. 2012 Aug 7;84(15):6731-8. doi: 10.1021/ac301191j. Epub 2012 Jul 12. Anal Chem. 2012. PMID: 22747067
-
Cytotoxicity of biologically synthesised bismuth nanoparticles against HT-29 cell line.IET Nanobiotechnol. 2018 Aug;12(5):653-657. doi: 10.1049/iet-nbt.2017.0295. IET Nanobiotechnol. 2018. PMID: 30095428 Free PMC article.
-
In situ transmission electron microscopy of solid-liquid phase transition of silica encapsulated bismuth nanoparticles.Nanoscale. 2011 Sep 1;3(9):3700-4. doi: 10.1039/c1nr10394f. Epub 2011 Jul 28. Nanoscale. 2011. PMID: 21796304
-
Synthesis, characterization, and X-ray attenuation properties of ultrasmall BiOI nanoparticles: toward renal clearable particulate CT contrast agents.Inorg Chem. 2014 Oct 6;53(19):10189-94. doi: 10.1021/ic5011709. Epub 2014 Sep 9. Inorg Chem. 2014. PMID: 25283335 Free PMC article.
-
Cytotoxicity of Laser-Synthesized Nanoparticles of Elemental Bismuth.Bull Exp Biol Med. 2024 Feb;176(4):501-504. doi: 10.1007/s10517-024-06055-6. Epub 2024 Mar 16. Bull Exp Biol Med. 2024. PMID: 38491259
Cited by
-
Medical Applications of Metallic Bismuth Nanoparticles.Pharmaceutics. 2021 Oct 26;13(11):1793. doi: 10.3390/pharmaceutics13111793. Pharmaceutics. 2021. PMID: 34834207 Free PMC article. Review.
-
Effect of Surface Functionalization on the Cellular Uptake and Toxicity of Nanozeolite A.Nanoscale Res Lett. 2016 Dec;11(1):123. doi: 10.1186/s11671-016-1334-8. Epub 2016 Mar 2. Nanoscale Res Lett. 2016. PMID: 26935303 Free PMC article.
-
Nanoparticle contrast agents for computed tomography: a focus on micelles.Contrast Media Mol Imaging. 2014 Jan-Feb;9(1):37-52. doi: 10.1002/cmmi.1551. Contrast Media Mol Imaging. 2014. PMID: 24470293 Free PMC article. Review.
-
Quantitative Phase Imaging as Sensitive Screening Method for Nanoparticle-Induced Cytotoxicity Assessment.Cells. 2024 Apr 17;13(8):697. doi: 10.3390/cells13080697. Cells. 2024. PMID: 38667312 Free PMC article.
-
Bioactive Bismuth Compounds: Is Their Toxicity a Barrier to Therapeutic Use?Int J Mol Sci. 2024 Jan 27;25(3):1600. doi: 10.3390/ijms25031600. Int J Mol Sci. 2024. PMID: 38338879 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous